Will changes in coverage limit your options?
Since so many men are using medications off-label this program should be of interest to prostate cancer advocates. About half of the use of anticancer chemotherapy drugs is for “off-label” indications – uses not listed on the FDA-approved label. Public and private payers typically cover off-label indications for anticancer drugs if they are listed in [...]
